AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study

RecruitingNAAges 18 Years - 80 YearsAllHuashan Hospital
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective study using a multicenter, randomized, controlled, open label, and efficacy validated approach.At present, there is no universally recognized optimal method for gastrointestinal reconstruction after proximal gastrectomy in the surgical treatment of gastric cancer.Author's team has proposed an innovative method named Hao's Esophagogastrostomay by Fisture Technique (HEFT).By adding anti reflux structures such as "false gastric fundus" and "false cardia" to the anastomosis of the residual stomach of the esophagus, not only can the purpose of anti reflux be achieved, but also the normal physiological channel can be maintained, it can fully utilize residual stomach function and reduce the difficulty of surgery.Through retrospective research, our single center has confirmed that HEFT is safe and feasible.On this basis, this study will compare the nutritional status, short

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. 18 years old ≤ 80 years old; 2. The primary tumor lesion is located in the upper part of the stomach or the esophagogastric junction (Siewert II or III), and it is expected that R0 surgical results can be obtained by performing proximal gastrectomy and D2 dissection; 3. The primary lesion was diagnosed as adenocarcinoma through endoscopic biopsy and histopathological examination; 4. If it is upper gastric adenocarcinoma, the clinical TNM staging based on imaging needs to be cT1N0M0. If it is ductal gastric junction adenocarcinoma, it needs to be cT1-3N0-1M0, and clinical imaging judgment shows no distant gastric lymph node metastasis; 5. Expected survival exceeds 6 months; 6. No history of upper abdominal surgery (excluding laparoscopic cholecystectomy); 7. No chemotherapy, radiotherapy, targeted therapy, immunotherapy, etc. were performed before surgery; 8. Preoperative ECOG (Eastern Cooperative Oncology Group) physical status score 0/1; 9. Preoperative ASA (American Society of Anesthesiologists) grading I-III ; 10. Good function of important organs; 11. Sign the patient's informed consent form Exclusion Criteria: 1. Preoperative imaging examination suggests the fusion of enlarged lymph nodes (maximum diameter ≥ 3cm) in the area; 2. Pregnant and lactating women; 3. Suffering from other malignant tumors within 5 years; 4. Preoperative body temperature ≥ 38 ℃ or complicated with infectious diseases requiring systematic treatment; 5. Serious mental illness; 6. Severe respiratory diseases, FEV1\<50% of the expected value; 7. Severe liver and kidney dysfunction; 8. History of unstable angina or heart attack within 6 months; 9. History of cerebral infarction or cerebral hemorrhage within 6 months, excluding old intracavitary infarction; 10. Apply systemic corticosteroid therapy within one month; 11. Patients with complications of gastric cancer (bleeding, perforation, obstruction) requiring emergency surgery; 12. The patient has participated or is currently participating in other clinical studies (within 6 months)
💊

What it tests

  • Totally laparoscopic proximal gastrectomy with Hao's esophagogastrostomy by fissure technique
  • Totally laparoscopic proximal gastrectomy with double-tract reconstruction
📍

Where

3 sites
Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Huashan Hospital, Fudan University
Shanghai, China
Second Department of Gastric Surgery, Fudan University Shanghai Cancer Center,
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy